DrugPatentWatch Database Preview
Litigation Details for Endo Pharmaceuticals Inc. v. Lupin Atlantis Holdings SA (E.D. Tex. 2017)
Endo Pharmaceuticals Inc. v. Lupin Atlantis Holdings SA (E.D. Tex. 2017)
| Docket | Start Trial | Date Filed | 2017-07-28 |
| Court | District Court, E.D. Texas | Date Terminated | 2018-06-22 |
| Cause | 35:271 Patent Infringement | Assigned To | James Rodney Gilstrap |
| Jury Demand | Plaintiff | Referred To | |
| Parties | ENDO PHARMACEUTICALS INC.; HARRY LEE GILLAM; LUPIN ATLANTIS HOLDINGS SA | ||
| Patents | 7,229,636; 7,404,489; 7,879,349; 8,003,353; 8,940,714; 9,415,007 | ||
| Attorneys | Jennifer Koh; Kurt A Mathas; Michael Brett Johnson; Michael Keenan Nutter; Sarah Wenxuan Wang; William Ellsworth Davis , III | ||
| Firms | Latham & Watkins - Chicago; Latham & Watkins LLP - San Diego; The Davis Firm, PC Longview; Winston & Strawn LLP - Chicago; Winston & Strawn LLP - Dallas | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Endo Pharmaceuticals Inc. v. Lupin Atlantis Holdings SA
The small molecule drug covered by the patents cited in this case is Start Trial .
Details for Endo Pharmaceuticals Inc. v. Lupin Atlantis Holdings SA (E.D. Tex. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | 1 | U.S. Patent No. 7,229,636, # 2 Exhibit B - U.S. Patent No. 7,404,489, # 3 Exhibit C - U.S. Patent No. …U.S. Patent No. 8,003,353, # 5 Exhibit E - U.S. Patent No. 8,940,714, # 6 Exhibit F - U.S. Patent No. … COMPLAINT for Patent Infringement against Lupin Atlantis Holdings SA ( Filing fee $ 400 receipt…2017 22 June 2018 2:17-cv-00558 835 Patent - Abbreviated New Drug Application(ANDA) | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
